Skip to main content
Caplight Logo









PharmCube

PharmCube

Private
ShanghaiHealthcare & Life Scienceshttps://pharmcube.com/

Last Round

Strategic

Nov 23, 2021

Total Funding Raised

$15.7M

Company Overview

PharmCube is a pharmaceutical big data company that provides data-driven intelligence, market insights, and consulting services to support decision-making across the drug development life cycle.

Sector

Healthcare & Life Sciences

Verticals

Business Intelligence, Healthcare Analytics, Clinical Trials, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

pharmaceutical intelligencebiotech dataclinical trial databasepharma market intelligencedrug development databiopharma analyticspharma data platformdrug pipeline screeninghealthcare investment datapharma competitive analysisdata as a serviceDaaSpharma SaaSbiotech intelligencepharma research tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmCube Comparables

Compare PharmCube with similar companies based on industry and business-model similarity.

PharmCube comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GBI
82%
重庆药智网络科技有限公司
82%
PatSnap
80%

PharmCube Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 23, 2021
Series BAug 21, 2020
Series A ExtensionDec 9, 2019
Series ASep 16, 2018
AngelJan 25, 2017

PharmCube Investors

Notable investors and investment history

PharmCube investors
InvestorRounds
Legend StarSeries A
Xingfu Investment ManagementSeries B
Tigeryeah CapitalSeries A Extension
Chongde CapitalSeries A
Apricot CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 35% MoM.

  • Aug 19, 2025

    Monthly visitors grew 49% MoM, reaching 994K.

PharmCube Filings

Explore SEC and related filing metadata, where available.

PharmCube filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PharmCube's valuation, stock price, and market status.

Is PharmCube a public or private company?

PharmCube is a private company.

What is the current stock price of PharmCube?

PharmCube is a private company with no public stock price. Caplight tracks PharmCube's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is PharmCube worth (valuation)?

Valuation information for PharmCube is not publicly available.

Can I buy PharmCube stock?

PharmCube shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PharmCube's last funding round?

PharmCube's most recent funding round was Strategic on November 23, 2021.

Who are the main investors in PharmCube?

Key investors in PharmCube include Xingfu Investment Management, Chongde Capital, Apricot Capital.

Will PharmCube IPO soon?

No public IPO plans have been announced for PharmCube.

How can I track PharmCube secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PharmCube's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Year Founded2015
Last FundingNov 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?